COMMUNITY OUTREACH AND ENGAGEMENT ? ABSTRACT Karmanos Cancer Institute (KCI) is the largest cancer research and care network in the state of Michigan. Headquartered in the city of Detroit, the KCI catchment area covers 46 of Michigan?s 83 counties, an area that is home to 6.7 million residents. KCI?s mission is to lead in transformative cancer care, research and education through courage, commitment and compassion. Dr. Hayley Thompson (PSDR), Associate Center Director for Community Outreach and Engagement, leads KCI?s efforts in support of this mission. Under her leadership, KCI has expanded its Community Outreach and Engagement (COE) efforts through the Office of Cancer Health Equity and Community Engagement (OCHECE). OCHECE?s activities are guided by a cancer surveillance strategy that captures data across four distinct catchment area regions that are diverse across race, ethnicity, and rurality. Activities are further guided by a participatory research approach in which community stakeholders are actively engaged in research prioritization, implementation, and dissemination. In 2016, OCHECE worked with range of community partners to establish Michigan Cancer HealthLink, a network of Cancer Action Councils (CACs) organized as neighborhood-based and population-driven groups of cancer survivors, caregivers, and advocates who have been historically excluded from meaningful research collaborations. The CAC infrastructure has provided a mechanism for community stakeholders to dialogue with researchers and inform the public relevance of KCI research across the Cancer Center?s four research Programs (Tumor Biology and Microenvironment, Molecular Imaging, Molecular Therapeutics, and Populations Studies and Disparities Research). These strategies of surveillance and engagement ensure that KCI research and outreach are aligned with the cancer burden in the catchment area.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA022453-39
Application #
10088980
Study Section
Special Emphasis Panel (ZCA1)
Project Start
1997-08-08
Project End
2025-11-30
Budget Start
2020-12-15
Budget End
2021-11-30
Support Year
39
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Wayne State University
Department
Type
DUNS #
001962224
City
Detroit
State
MI
Country
United States
Zip Code
48202
Herroon, Mackenzie K; Rajagurubandara, Erandi; Diedrich, Jonathan D et al. (2018) Adipocyte-activated oxidative and ER stress pathways promote tumor survival in bone via upregulation of Heme Oxygenase 1 and Survivin. Sci Rep 8:40
Colacino, Justin A; Azizi, Ebrahim; Brooks, Michael D et al. (2018) Heterogeneity of Human Breast Stem and Progenitor Cells as Revealed by Transcriptional Profiling. Stem Cell Reports 10:1596-1609
Blocker, Stephanie J; Shields, Anthony F (2018) Imaging of Nanoparticle Distribution to Assess Treatments That Alter Delivery. Mol Imaging Biol 20:340-351
Guastella, Anthony R; Michelhaugh, Sharon K; Klinger, Neil V et al. (2018) Investigation of the aryl hydrocarbon receptor and the intrinsic tumoral component of the kynurenine pathway of tryptophan metabolism in primary brain tumors. J Neurooncol 139:239-249
Li, Feng; Wang, Yongli; Li, Dapeng et al. (2018) Perspectives on the recent developments with green tea polyphenols in drug discovery. Expert Opin Drug Discov 13:643-660
Ramseyer, Vanesa D; Kimler, Victoria A; Granneman, James G (2018) Vacuolar protein sorting 13C is a novel lipid droplet protein that inhibits lipolysis in brown adipocytes. Mol Metab 7:57-70
Healy, Mark A; Morris, Arden M; Abrahamse, Paul et al. (2018) The accuracy of chemotherapy ascertainment among colorectal cancer patients in the surveillance, epidemiology, and end results registry program. BMC Cancer 18:481
Lacher, Sarah E; Alazizi, Adnan; Wang, Xuting et al. (2018) A hypermorphic antioxidant response element is associated with increased MS4A6A expression and Alzheimer's disease. Redox Biol 14:686-693
Alsaab, Hashem O; Sau, Samaresh; Alzhrani, Rami M et al. (2018) Tumor hypoxia directed multimodal nanotherapy for overcoming drug resistance in renal cell carcinoma and reprogramming macrophages. Biomaterials 183:280-294
Chammaa, May; Malysa, Agnes; Redondo, Carlos et al. (2018) RUMI is a novel negative prognostic marker and therapeutic target in non-small-cell lung cancer. J Cell Physiol 233:9548-9562

Showing the most recent 10 out of 826 publications